On May 28, 2025, Revelation Biosciences, Inc. announced a public offering of 675,000 shares of common stock and pre-funded warrants, raising approximately $4.0 million, which closed the following day. The offering included warrants exercisable at $1.10 per share, and associated agreements were established with Roth Capital Partners.